東和薬品の株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2021/08/19 | 3,040 | 3,075 | 2,980 | 2,980 | -90 | -2.9% | 107,900 |
2021/08/18 | 3,060 | 3,095 | 3,060 | 3,070 | +30 | +1% | 95,700 |
2021/08/17 | 3,080 | 3,110 | 3,030 | 3,040 | -40 | -1.3% | 117,100 |
2021/08/16 | 3,105 | 3,115 | 2,986 | 3,080 | ±0 | ±0% | 192,000 |
2021/08/13 | 2,969 | 3,090 | 2,944 | 3,080 | +157 | +5.4% | 197,700 |
2021/08/12 | 2,970 | 2,987 | 2,915 | 2,923 | -30 | -1% | 98,600 |
2021/08/11 | 2,947 | 2,967 | 2,929 | 2,953 | +31 | +1.1% | 88,800 |
2021/08/10 | 2,949 | 2,970 | 2,916 | 2,922 | +9 | +0.3% | 90,700 |
2021/08/06 | 2,914 | 2,934 | 2,911 | 2,913 | +31 | +1.1% | 50,800 |
2021/08/05 | 2,910 | 2,940 | 2,882 | 2,882 | -37 | -1.3% | 75,900 |
2021/08/04 | 2,927 | 2,948 | 2,897 | 2,919 | -16 | -0.5% | 85,700 |
2021/08/03 | 2,880 | 2,936 | 2,873 | 2,935 | +50 | +1.7% | 156,900 |
2021/08/02 | 2,823 | 2,908 | 2,823 | 2,885 | +95 | +3.4% | 146,100 |
2021/07/30 | 2,777 | 2,804 | 2,766 | 2,790 | -12 | -0.4% | 102,300 |
2021/07/29 | 2,794 | 2,804 | 2,781 | 2,802 | +15 | +0.5% | 103,800 |
2021/07/28 | 2,780 | 2,815 | 2,775 | 2,787 | +10 | +0.4% | 93,800 |
2021/07/27 | 2,750 | 2,777 | 2,746 | 2,777 | +38 | +1.4% | 108,800 |
2021/07/26 | 2,730 | 2,745 | 2,710 | 2,739 | +46 | +1.7% | 75,200 |
2021/07/21 | 2,696 | 2,709 | 2,670 | 2,693 | +35 | +1.3% | 80,900 |
2021/07/20 | 2,656 | 2,660 | 2,613 | 2,658 | +2 | +0.1% | 82,000 |
2021/07/19 | 2,644 | 2,669 | 2,621 | 2,656 | -21 | -0.8% | 97,300 |
2021/07/16 | 2,670 | 2,697 | 2,657 | 2,677 | +5 | +0.2% | 94,500 |
2021/07/15 | 2,689 | 2,703 | 2,661 | 2,672 | +5 | +0.2% | 105,800 |
2021/07/14 | 2,625 | 2,679 | 2,619 | 2,667 | +42 | +1.6% | 78,300 |
2021/07/13 | 2,580 | 2,633 | 2,572 | 2,625 | +76 | +3% | 169,300 |
2021/07/12 | 2,560 | 2,560 | 2,532 | 2,549 | +39 | +1.6% | 99,700 |
2021/07/09 | 2,495 | 2,521 | 2,462 | 2,510 | +3 | +0.1% | 138,000 |
2021/07/08 | 2,555 | 2,559 | 2,507 | 2,507 | -43 | -1.7% | 127,600 |
2021/07/07 | 2,569 | 2,582 | 2,518 | 2,550 | -119 | -4.5% | 243,900 |
2021/07/06 | 2,675 | 2,690 | 2,654 | 2,669 | -19 | -0.7% | 49,800 |
2021/07/05 | 2,735 | 2,737 | 2,683 | 2,688 | -62 | -2.3% | 98,700 |
2021/07/02 | 2,748 | 2,770 | 2,724 | 2,750 | +5 | +0.2% | 125,800 |
2021/07/01 | 2,704 | 2,749 | 2,674 | 2,745 | +41 | +1.5% | 110,400 |
2021/06/30 | 2,720 | 2,728 | 2,674 | 2,704 | -28 | -1% | 134,400 |
2021/06/29 | 2,765 | 2,765 | 2,719 | 2,732 | -25 | -0.9% | 120,900 |
2021/06/28 | 2,720 | 2,761 | 2,707 | 2,757 | +73 | +2.7% | 185,600 |
2021/06/25 | 2,680 | 2,689 | 2,654 | 2,684 | +29 | +1.1% | 82,800 |
2021/06/24 | 2,642 | 2,689 | 2,635 | 2,655 | -1 | ±0% | 71,600 |
2021/06/23 | 2,673 | 2,700 | 2,646 | 2,656 | -17 | -0.6% | 80,500 |
2021/06/22 | 2,617 | 2,673 | 2,609 | 2,673 | +84 | +3.2% | 127,800 |
2021/06/21 | 2,558 | 2,593 | 2,545 | 2,589 | +18 | +0.7% | 104,000 |
2021/06/18 | 2,604 | 2,616 | 2,558 | 2,571 | -33 | -1.3% | 103,100 |
2021/06/17 | 2,622 | 2,643 | 2,603 | 2,604 | -15 | -0.6% | 73,800 |
2021/06/16 | 2,580 | 2,624 | 2,562 | 2,619 | +16 | +0.6% | 58,900 |
2021/06/15 | 2,622 | 2,622 | 2,580 | 2,603 | -21 | -0.8% | 86,700 |
2021/06/14 | 2,585 | 2,658 | 2,582 | 2,624 | +50 | +1.9% | 136,700 |
2021/06/11 | 2,566 | 2,577 | 2,548 | 2,574 | +12 | +0.5% | 94,500 |
2021/06/10 | 2,548 | 2,570 | 2,536 | 2,562 | +14 | +0.5% | 129,500 |
2021/06/09 | 2,538 | 2,564 | 2,530 | 2,548 | +28 | +1.1% | 108,000 |
2021/06/08 | 2,510 | 2,546 | 2,503 | 2,520 | +11 | +0.4% | 93,700 |
801~
850
件表示中 / 6839件
類似銘柄と比較する
現在ご覧いただいている「東和薬品」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
東和薬品 | 282,000円 | +15.0% | -7.3% | 2.13% | 9.25倍 | 0.87倍 |
|
後発医薬品メーカーで国内2強の一角。循環器系に強い。直販軸に発展も卸との取引を拡大中 |
科研薬 | 446,100円 | +22.8% | +113.0% | 4.26% | 11.90倍 | 1.09倍 |
|
旧理研グループの名門。導入の関節機能改善剤、自社創製の爪白癬症薬の2本柱。後発品も展開 |
キッセイ薬 | 365,500円 | +14.5% | -2.3% | 2.46% | 13.37倍 | 0.71倍 |
|
医薬品中堅。泌尿器、腎・透析、未充足医療が重点領域。主軸特許切れ、新しい柱育成。海外は導出 |
ジーエヌアイ | 281,400円 | +52.1% | +23.3% | 0.00% | 19.98倍 | 3.83倍 |
|
中国の特発性肺線維症で高シェア、肺線維症後続薬進出。米国で人工骨も。米中に研究開発機能 |
鳥居薬 | 476,000円 | +12.0% | +28.1% | 2.52% | 26.24倍 | 1.11倍 |
|
JT傘下。柱の抗HIV薬販売権喪失後、自社製品の腎・透析、アレルゲン等の開発強化 |
市場注目の銘柄
チャート関連のコラム